AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitasafe-M Tablet

Prescription Icon
Prescription Required

Marketer

Dr. Ethix's Product & Services Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitasafe-M Tablet

Diabetam-Duo tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events like stroke or myocardial infarction. Diabetam-Duo may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved when coupled with a balanced diet and consistent physical activity. Dosage is individualized based on your health status, blood glucose readings, and other concurrent medications. Consuming the tablets with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact glycemic control. Commonly reported side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; understanding hypoglycemia recognition and management is essential. This medication isn't suitable for all individuals. Prior to initiating treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Potential drug interactions exist; disclose all medications to your doctor to ensure treatment safety. Alcohol should be avoided due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout your treatment.

Uses of Sitasafe-M Tablet

Managing type 2 diabetes

Major Benefits of Sitasafe-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitasafe-M Tablet with a meal.

Common Side effects of Sitasafe-M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitasafe-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitasafe-M Tablet with a meal.

How Sitasafe-M Tablet works:

Sitagliptin and metformin, the components of Sitasafe-M Tablet, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitasafe-M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitasafe-M Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Sitasafe-M tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitasafe-M Tablets cautiously, potentially requiring dosage modification. Consult your physician. Sitasafe-M Tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Use of Sitasafe-M Tablets is contraindicated in individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitasafe-M Tablet :

Should you forget a Sitasafe-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitasafe-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitasafe-M Tablet

Sitasafe-M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitasafe-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitasafe-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasafe-M Tablets are contraindicated in patients with hypersensitivity to any component. Avoid use in patients with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe-M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Sitagliptin + Metformin (Sitasafe-M Tablet) can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitasafe-M and seek immediate medical attention.
Sitasafe-M Tablets combine sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitasafe-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitasafe-M Tablets are contraindicated in patients with allergies to any ingredient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe-M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitasafe-M Tablet) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitasafe-M and seek immediate medical attention.
Prolonged Sitasafe-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and balance problems), urinary difficulties, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasafe-M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitasafe-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasafe-M Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe-M Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitasafe-M Tablet) can, rarely, cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is heightened in patients with kidney disease, the elderly, and those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitasafe-M and seek immediate medical attention.
Prolonged Sitasafe-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasafe-M Tablet
211
MRP 245
13% off